Notes
2013 US dollars
Reference
Smolen LJ, et al. The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective. Clinical Therapeutics : 3 Jun 2016. Available from: URL: http://doi.org/10.1016/j.clinthera.2016.05.007
Rights and permissions
About this article
Cite this article
Febuxostat for gout: long-term savings in medical costs. PharmacoEcon Outcomes News 756, 22 (2016). https://doi.org/10.1007/s40274-016-3171-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3171-5